Eukaryotic initiation factor 4 gamma 2 contributes to neuropathic pain through down-regulation of Kv1.2 and the mu opioid receptor in mouse primary sensory neurones-Reference-Cited by-同舟云学术

Eukaryotic initiation factor 4 gamma 2 contributes to neuropathic pain through down-regulation of Kv1.2 and the mu opioid receptor in mouse primary sensory neurones

Published:2021-03 Issue:3 Volume:126 Page:706-719
ISSN:0007-0912
Container-title:British Journal of Anaesthesia
language:en
Short-container-title:British Journal of Anaesthesia

Author:

Zhang Zhen,Zheng Bixin,Du Shibin,Han Guang,Zhao Hui,Wu Shaogen,Jia Shushan,Bachmann Thomas,Bekker Alex,Tao Yuan-Xiang

Funder

National Institute of Neurological Disorders and Stroke

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine

Reference44 articles.

1. Neuropathic pain: mechanisms and their clinical implications;Cohen;BMJ,2014

2. The economic costs of pain in the United States;Gaskin;J Pain,2012

3. Mechanisms of neuropathic pain;Campbell;Neuron,2006

4. G9a is essential for epigenetic silencing of K(+) channel genes in acute-to-chronic pain transition;Laumet;Nat Neurosci,2015

5. Dorsal root ganglion transcriptome analysis following peripheral nerve injury in mice;Wu;Mol Pain,2016

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA-binding protein SYNCRIP contributes to neuropathic pain through stabilising CCR2 expression in primary sensory neurones;British Journal of Anaesthesia;2024-09

2. ESRRG-controlled downregulation of KCNN1 in primary sensory neurons is required for neuropathic pain;JCI Insight;2024-05-21

3. Repressing iron overload ameliorates central post-stroke pain via the Hdac2-Kv1.2 axis in a rat model of hemorrhagic stroke;Neural Regeneration Research;2024-04-01

4. Emerging Molecular and Synaptic Targets for the Management of Chronic Pain Caused by Systemic Lupus Erythematosus;International Journal of Molecular Sciences;2024-03-22

5. Peripheral blood RNA biomarkers can predict lesion severity in degenerative cervical myelopathy;Neural Regeneration Research;2024-01-31